VREX Quote, Financials, Valuation and Earnings

Hologic has a net margin of 3.24% compared to Varex Imaging's net margin of -1.73%. Varex Imaging's return on equity of -7.36% beat Hologic's return on equity of 11.45%.

Varex Imaging has a consensus price target of $16.60, signalling upside risk potential of 103.18%. On the other hand Hologic has an analysts' consensus of $69.01 which suggests that it could grow by 5%. Given that Varex Imaging has higher upside potential than Hologic, analysts believe Varex Imaging is more attractive than Hologic.

Varex Imaging has a beta of 0.697, which suggesting that the stock is 30.263% less volatile than S&P 500. In comparison Hologic has a beta of 0.553, suggesting its less volatile than the S&P 500 by 44.736%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Hologic pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $212.9M, which are smaller than Hologic quarterly revenues of $1B. Varex Imaging's net income of $6.9M is higher than Hologic's net income of -$17.4M. Notably, Varex Imaging's price-to-earnings ratio is 17.58x while Hologic's PE ratio is 27.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.43x versus 3.80x for Hologic. Usually stocks with elevated PS ratios are considered overvalued.

Myomo has a net margin of 3.24% compared to Varex Imaging's net margin of -35.24%. Varex Imaging's return on equity of -7.36% beat Myomo's return on equity of -38.11%.

Varex Imaging has a consensus price target of $16.60, signalling upside risk potential of 103.18%. On the other hand Myomo has an analysts' consensus of $8.70 which suggests that it could grow by 318.27%. Given that Myomo has higher upside potential than Varex Imaging, analysts believe Myomo is more attractive than Varex Imaging.

Varex Imaging has a beta of 0.697, which suggesting that the stock is 30.263% less volatile than S&P 500. In comparison Myomo has a beta of 1.389, suggesting its more volatile than the S&P 500 by 38.863%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $212.9M, which are larger than Myomo quarterly revenues of $9.8M. Varex Imaging's net income of $6.9M is higher than Myomo's net income of -$3.5M. Notably, Varex Imaging's price-to-earnings ratio is 17.58x while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.43x versus 2.10x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.

Nuwellis has a net margin of 3.24% compared to Varex Imaging's net margin of -158.3%. Varex Imaging's return on equity of -7.36% beat Nuwellis's return on equity of -670.55%.

Varex Imaging has a consensus price target of $16.60, signalling upside risk potential of 103.18%. On the other hand Nuwellis has an analysts' consensus of $13.00 which suggests that it could grow by 6615.12%. Given that Nuwellis has higher upside potential than Varex Imaging, analysts believe Nuwellis is more attractive than Varex Imaging.

Varex Imaging has a beta of 0.697, which suggesting that the stock is 30.263% less volatile than S&P 500. In comparison Nuwellis has a beta of 0.281, suggesting its less volatile than the S&P 500 by 71.882%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nuwellis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Nuwellis pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $212.9M, which are larger than Nuwellis quarterly revenues of $1.9M. Varex Imaging's net income of $6.9M is higher than Nuwellis's net income of -$3M. Notably, Varex Imaging's price-to-earnings ratio is 17.58x while Nuwellis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.43x versus 0.88x for Nuwellis. Usually stocks with elevated PS ratios are considered overvalued.

Quanterix has a net margin of 3.24% compared to Varex Imaging's net margin of -67.73%. Varex Imaging's return on equity of -7.36% beat Quanterix's return on equity of -14.39%.

Varex Imaging has a consensus price target of $16.60, signalling upside risk potential of 103.18%. On the other hand Quanterix has an analysts' consensus of $11.25 which suggests that it could grow by 91%. Given that Varex Imaging has higher upside potential than Quanterix, analysts believe Varex Imaging is more attractive than Quanterix.

Varex Imaging has a beta of 0.697, which suggesting that the stock is 30.263% less volatile than S&P 500. In comparison Quanterix has a beta of 1.127, suggesting its more volatile than the S&P 500 by 12.667%.

Varex Imaging has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quanterix offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Varex Imaging pays -- of its earnings as a dividend. Quanterix pays out -- of its earnings as a dividend.

Varex Imaging quarterly revenues are $212.9M, which are larger than Quanterix quarterly revenues of $30.3M. Varex Imaging's net income of $6.9M is higher than Quanterix's net income of -$20.5M. Notably, Varex Imaging's price-to-earnings ratio is 17.58x while Quanterix's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Varex Imaging is 0.43x versus 1.69x for Quanterix. Usually stocks with elevated PS ratios are considered overvalued.